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AbsTrACT
Introduction Estimates suggest that one in two deaths 
go unrecorded globally every year in terms of medical 
causes, with the majority occurring in low and middle-
income countries (LMICs). This can be related to low 
investment in civil registration and vital statistics (CRVS) 
systems. Verbal autopsy (VA) is a method that enables 
identification of cause of death where no other routine 
systems are in place and where many people die at 
home. Considering the utility of VA as a pragmatic, 
interim solution to the lack of functional CRVS, this 
review aimed to examine the use of VA to inform health 
policy and systems improvements.
Methods A literature review was conducted including 
papers published between 2010 and 2017 according to a 
systematic search strategy. Inclusion of papers and data 
extraction were assessed by three reviewers. Thereafter, 
thematic analysis and narrative synthesis were conducted 
in which evidence was critically examined and key themes 
were identified.
results Twenty-six papers applying VA to inform health 
policy and systems developments were selected, including 
studies in 15 LMICs in Africa, Asia, the Middle East and 
South America. The majority of studies applied VA in 
surveillance sites or programmes actively engaging with 
decision makers and governments in different ways and 
to different degrees. In the papers reviewed, the value of 
continuous collection of cause of death data, supplemented 
by social and community-based investigations and 
underpinned by electronic data innovations, to establish a 
robust and reliable evidence base for health policies and 
programmes was clearly recognised.
Conclusion VA has considerable potential to inform 
policy, planning and measurement of progress towards 
goals and targets. Working collaboratively at sub-
national, national and international levels facilitates 
data collection, aggregation and dissemination linked to 
routine information systems. When used in partnerships 
between researchers and authorities, VA can help to close 
critical information gaps and guide policy development, 
implementation, evaluation and investment in health 
systems.
InTroduCTIon
It is vitally important that data on cause of 
death are available, reliable, timely, and 
collected and aggregated at low cost for a 
robust evidence base to inform strategic 
health policy and evaluation.1 Collecting 
data on births and deaths including cause 
of death in high-income countries relies on 
well-established civil registration and vital 
statistics (CRVS) systems. However, in many 
low and middle-income countries (LMICs), 
there is a pervasive lack of death registration 
inclusive of notification of medical cause of 
death due to low investment over decades.1 2 
This situation highlights an important gap, 
as one in two deaths go unreported globally, 
the majority occurring in LMICs.1 3 
Key questions
What is already known?
 ► Verbal autopsy (VA) is an established health 
surveillance method that provides information on 
levels and causes of death in populations where 
medical death certification is weak or absent.
 ► From 1998 to 2010, methodological and technical 
developments and high level advocacy have 
transitioned VA from use in research environments 
towards pragmatic applications on a wider scale, 
including in routine registration.
 ► An extensive literature exists on the validity of VA 
and applications in research settings. Information 
on its use in health policy and systems, ie on 
working with health authorities to provide evidence 
for action, is less common by comparison.
What are the new findings?
 ► Since 2010, applications of VA in health policy and 
systems were identified in 15 low and middle-
income countries. There were various forms and 
extents of engagement with decision makers and 
governments.
 ► Advancements in electronic data collection, 
automated data interpretation and electronic 
databases have supported collaboration in terms 
of data sharing, and monitoring and evaluation of 
disease burdens.
 ► When combined with complementary methods, 
such as, social autopsy, the explanatory potential 
of VA is extended to identify contributory factors in 
conjunction with information on levels and causes 
of deaths in populations.
 ► Active engagement with decision makers and 
communities was seen to help establish a relevant 
evidence-base that directly informs the means for 
action.
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The importance of recording vital events through 
improved CRVS systems is well recognised. The Lancet 
series ‘Who counts?’ in 20074 and ‘Counting births and deaths’ 
in 20155 emphasised the significance of robust data on 
vital events.6 There is also increasing recognition among 
the global health community that progress towards 
universal health coverage (UHC) depends on effective 
monitoring of equitable coverage and utilisation.7 8 To 
achieve goals such as UHC and the Sustainable Devel-
opment Goals (SDGs), countries need functional CRVS 
systems, and the collection of data on deaths of people 
excluded from access to health systems is an important 
step for addressing health inequalities and saving lives.9
Verbal autopsy (VA) is a method that can be used to 
collect and analyse data on cause of death.  VA is defined 
by the WHO as ‘a method used to ascertain the cause of a death 
based on an interview with next of kin or other caregivers’ that 
can be applied for deaths without certification of medical 
causes.2 Its main objective is to deliver a simple identi-
fication of cause of death at community or population 
level in countries where no other functional registration 
system is in place and/or where many people die at home 
without contact with the health system.2 Over the past 25 
years, VA has become a primary source of information 
about cause of death in several LMICs.2
The development of VA can be traced back to the 
1950s and 1960s, where researchers in Asia and Africa 
used physician interviews with relatives and carers of 
deceased persons to assess cause of death and generate 
cause of death statistics.10 Workers from the Narangwal 
project in India named this technique VA.11 In the 1970s, 
the method gained attention when WHO encouraged 
the use of ‘lay reporting’ by people with no medical 
training.12 Subsequently, Reproductive Age Mortality 
Studies, Matlab (Bangladesh) and Niakhar (Senegal) 
developed VA questionnaires to ascertain possible cause 
of death diagnosis in the late 1970s and early 1980s, 
which are still used in research settings and national/
regional surveys.2 13
Concerns about the validity of instruments and compa-
rability of data arose in the early 1990s and led to the 
convening of expert committees to develop standardised 
VA tools for childhood and maternal deaths,14 15 leading 
to the development of VA standards for maternal deaths 
in 1994.16 In 2007, the WHO published three standard VA 
questionnaires, ‘death of a child aged under four weeks’, 
‘death of a child aged four weeks to 14 years’ and ‘death 
of a person aged 15 years and above’.2 These tools sought 
to permit certification and coding commensurate with 
International Statistical Classification of Diseases and 
Related Health Problems, 10th Revision (ICD-10) and 
ascertain all causes of death with reasonable accuracy 
drawing on well-administered VA interviews.2 The stan-
dards were updated in 2012, 2014 and 2016 to improve 
cause-specific mortality data and to ensure consistency 
and comparability between countries.10 Appendix 1 
contains a description of the development of the WHO 
VA standards from 2012-2016 (online  supplementary 
appendix 1).
In its present form, VA typically consists of two main 
stages. First, information is collected via structured inter-
views with family members and caregivers of the deceased 
on their signs, symptoms, medical history and circum-
stances at and around the time of death.2 Second, interview 
data are interpreted by physicians (Physician-Certified 
VA, [PCVA]1 17) or using automated methods (‘Comput-
erised Coding of VA’ [CCVA]) for example, InterVA and 
SmartVA, using algorithms and probability theory,1 18 to 
obtain probable cause(s) of death.
The method is applied in a range of study designs and 
research settings: clinical trials and large-scale epidemi-
ological studies, health and demographic surveillance 
systems (HDSS), national sample surveillance systems, 
and household surveys.1 2 The resulting data can help 
to determine gaps in vital statistics and help to establish 
population-level disease burden estimates.19 Further-
more, it can assist in monitoring and evaluation of health 
policy, planning and instituting programmes.
Due to the lack of effective national CRVS systems 
in many LMICs, statistics on disease burdens are often 
calculated by researchers using prediction models and 
estimation procedures.20 Alternative approaches to 
provide reliable sources of vital data are HDSS or Sample 
Vital Registration with verbal autopsy (SAVVY) systems. 
While surveys collect information from a representative 
population sample,21 HDSS and SAVVY systems aim to 
regularly monitor ‘demographic and health characteristics of 
a population living in a well-defined geographical area’ and 
collect prospective, longitudinal data.20
VA has been used to investigate population health in 
selected contexts by examining sequences of events in 
detail, particularly rare events, for example, maternal 
deaths.21 HDSSs are commonly situated in deprived rural, 
semiurban or urban areas where generalisability is condi-
tional on a geographically, well-identified context.21 VA 
is frequently used in HDSS contexts to determine levels 
and causes of deaths for surveillance populations. Rather 
than precise descriptions of events at a given time, HDSS 
focus on the relationships between events at the commu-
nity, household and individual levels over time.21 The 
Key questions
What do the new findings imply?
 ► VA has significant potential in health policy and systems to deliver 
robust and reliable evidence, help close gaps in statistics, and 
guide implementation, evaluation and investment.
 ► In conjunction with complementary data collection efforts, 
VA can contribute to more holistic views of health systems 
performance combining evidence on burden of disease with social 
determinants and local knowledge.
 ► The active collaboration of various stakeholders: governments, 
health authorities, communities and research groups, can foster 
engagement in, and coverage of, data collection and enhance the 
validity and utility of the process.
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information generated can help to evaluate the effects of, 
and give evidentiary support to, the scaling up of inter-
ventions.20 Furthermore, HDSS data collected and 
analysed with standardised tools, compared and cross-val-
idated with national and international data, has shown 
extensive conformity, for example, recently with data 
from the International Network for the Demographic 
Evaluation of Populations and their Health (INDEPTH) 
and Global Burden of Disease estimates, which supports 
generalisability beyond specific surveillance sites.21
VA is a well established surveillance method used 
in over 45 LMICs for over 25 years mainly in research 
settings, and/or as part of large household surveys to 
calculate disease burdens in populations.9 Developments 
in VA tools and analysis, combined with wider recogni-
tion of the dearth of mortality data globally, have led to 
VA being recognised as a valuable, interim approach for 
use outside research environments, and towards use in 
CRVS systems.22 On this basis, this review is concerned 
with how VA has been used to inform health systems, 
policy and management in LMICs.
Major collaborative networks also support the use of 
VA, eg initiatives such as ‘Bloomberg Data for Health’, 
a network of local and national authorities in 20 LMICs, 
seek to strengthen the collection and use of critical 
public health information using the method. One of the 
key objectives of the initiative is to provide resources to 
understand broad systems issues, as well as promote the 
integration of VA data into CRVS systems, enhancing the 
use of data for maximum impact in policymaking and 
priority setting.23 24
Furthermore, the Million Death Study (MDS) in India 
(1998–2014), one of the largest studies of premature 
mortality in the world, involves the use of VA on a large 
scale, to influence policy and decision making. The MDS 
worked in collaboration with the Registrar General of 
India, which since 2002 has integrated an enhanced 
form of VA into its large-scale, nationally representative 
Sample Registration System.25 Monitoring births and 
deaths that occur outside healthcare facilities with VA 
in approximately one million randomly selected house-
holds has provided invaluable information to govern-
ments, research agencies and media, leading to action 
against preventable deaths.26
The wider use of VA is often hampered by concerns 
about validity. While there have been several studies 
investigating this issue, their findings need careful 
consideration. Medical autopsies and hospital records 
in LMICs are often of poor quality.27 However, these are 
frequently used as a ‘gold standard’ in testing the validity 
of VA. Validation studies are therefore a comparison of 
two imperfect cause of death assignments.27 To this end, 
the Population Health Metrics Consortium (PHMRC) 
conducted research in four countries documenting 
deaths in high-level hospitals and followed these up with 
VA, developing a data set labelled as ‘gold standard’ VA 
data.28 However, the authors acknowledged that even 
though the VA data might have achieved internal validity, 
the external validity was likely to have been limited.28 
While VA may be seen as an imperfect tool for ascer-
taining cause of death, it is often the only alternative in 
the absence of medical certification.22
A further stream of methodological development 
aims to combine VA with social autopsy (SA). SA is a 
method aiming to ‘collect the data needed to connect the 
fatal illness or the act of diagnosing or recognizing that illness 
to a set of socio-demographic, economic, cultural conditions 
or factors’ representing a social diagnosis of the death.29 
Relative to VA, SA is a novel approach, which has not 
been widely practised and still lacks standardisation 
for data collection and analysis to the extent seen with 
VA.30 Current work by the Child Health Epidemiology 
Reference Group (CHERG) and INDEPTH seeks to 
arrive at standardised SA tools.31 Methodologists posit 
that VA combined with SA provides enhanced data 
that can generate more holistic information on causes 
and determinants of deaths and situate cause of death 
in a richer account of context.32 In addition, ‘VASA’ 
(verbal autopsy and social autopsy) studies have 
been conducted in Bangladesh (2007–2011), Malawi 
(2011–2012), Niger (2012–2013) and Nigeria (2013), 
using retrospective surveys for data collection.32 VASA 
data have also been incorporated into updates of 
modelled data as part of global and regional mortality 
estimates, supplemented national mortality estimates, 
and informed policy and programme development.32
Aims and objectives
Considering the methodological developments and 
global recognition of the broader use of VA both for 
research and policy development, the contribution of 
this paper is twofold: first, it aims to examine how VA 
is used to inform the operation of health systems (ie, 
beyond surveillance or condition-specific purposes); 
and second, to identify and review how VA is used in an 
‘embedded’ manner in health policy and systems devel-
opment. That is, with and for health authorities, aligning 
to and reflecting the realities of implementation33 and 
informing action. It updates a previous review by Fottrell 
and Byass, charting the methodological transition of VA 
from research environment to routine application in 
CRVS systems13 with a focus on the use of VA to inform 
health system and policy research and development.
MeTHods
The review was conducted using a systematic search 
strategy. Information was gathered on implementation 
features, the use and purpose of VA to strengthen health 
policy and systems, and strengths and limitations of the 
approaches used.
search strategy
We examined online databases, including PubMed, 
POPLINE, Web of Science and Scopus using combina-
tions of keywords and phrases (figure 1). Further sources 
and especially grey literature were identified through 
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manual searches of references quoted in original publi-
cations. Additional hand searches and web searches 
were conducted on organisational portals, for example, 
Centres for Disease Control and Prevention, INDEPTH, 
CHERG and PHMRC, to identify further papers. The 
time frame 2010–2017 was defined as a key paper on VA 
considering its methodological transition was published 
in 2010.13
Inclusion and exclusion criteria
Inclusion criteria were as follows: (1) papers published 
after 2010 in a journal or reports accessible through web 
search; (2) papers that described engagement in health 
systems to employ VA findings and (3) papers written in 
English. Studies that did not describe a contribution to 
health systems and policy strengthening and/or health 
policy and systems research by identifying needs or 
changes in policies and practice (eg, reforms to secure 
healthier communities)34 were excluded.
data extraction and analysis
A form was developed to extract data from retrieved 
articles on (1) study setting; (2) stated objective(s); 
(3) VA/SA method used; (4) remarks/limitations on 
the use of VA in health policy and system research; (5) 
applicability for health systems and policy strengthening 
and/or research; and (6) key findings. Articles were 
selected and reviewed, and data were extracted from the 
retrieved studies by one reviewer (LMT). Subsequently, 
data extraction was performed independently by two 
reviewers (LD and DB). Thereafter, data extractions 
were collated from all reviewers, and divergences were 
identified and resolved via discussion. Thematic analysis 
and narrative synthesis were subsequently conducted to 
analyse the data extracted. Themes and subthemes that 
emerged from the literature were identified, compared, 
discussed and associated with each other by the reviewers 
to ensure plausibility, validity and consistency. In accord-
ance to the aims and objectives of the review, a framework 
was developed to demonstrate the extent of use of VA/
SA in health policy and systems. The framework deline-
ated a range of uses comprising: (1) disease-specific or 
vertical donor-driven policies and programmes, seeking 
to measure specified programme outcomes; (2) analysis 
and interpretation of information at the health system 
level, seeking to capture a broader range of (intended 
and unintended) outcomes and considerations for health 
policies; and (3) ‘embedded in policy’ processes at the 
system level, that is, active engagement with the Depart-
ment of Health or Ministry of Health (MOH) (figure 2).
The methodological quality of included studies 
was assessed by the reviewers using the relevant Crit-
ical Appraisal Skills Programme (CASP) checklists35 
for qualitative studies and an adapted version of the 
Effective Public Health Practice Project (EPHPP)36 
Figure 2 Framework: continuum of the use of verbal autopsy in health policy and systems.
Figure 1 Search strategy used for PubMed, POPLINE and Scopus.
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assessment tool for quantitative studies. The tool usually 
involves rating articles (strong, moderate, weak) on six 
components: selection bias, study design, confounders, 
blinding, data collection methods, withdrawals and drop-
outs. In the modified version developed, the blinding 
section was disregarded as studies containing VA do not 
usually involve blinding, and so inclusion of this compo-
nent would have had a misleading adverse impact on the 
quality assessment. The quality appraisal process sought 
to identify common strengths and weaknesses, rather 
than to exclude studies. All studies were analysed and 
used in the analysis with strengths and weaknesses taken 
into account.
resulTs
search results
The search identified 634 articles. 362 publications were 
identified through PubMed, while 132, 117 and 23 publi-
cations were identified through Scopus, Web of Science 
and POPLINE respectively. An additional eight papers 
were identified through hand searches. After title and 
abstract review, 26 publications were considered eligible 
for the review (figure 3).
study characteristics
From the selected papers, 14 were research papers.22 25 37–49 
Seven were quantitative, from which the rating according 
to the EPHPP tool was strong for two articles, moderate 
for four, and weak for one.38–40 43 45–47 According to the 
CASP tool, the one qualitative study identified had a 
low risk of bias.49 Three papers were considerations of 
contextual factors for systems integrating VA,22 25 44 and 
two investigated feasibility issues (one of community 
informants and one, the cost of VA in a mortality surveil-
lance system).42 48 One was a pilot study that identified 
weaknesses in an existing maternal death review system 
and introduced a community-based process to improve 
the recording of maternal deaths.37 From the remaining 
papers, four were HDSS profiles,50–53 four were corre-
spondences/commentaries,54–57 two were information 
sheets,41 58 one was a summary of study results59 and one 
was a research proposal.60 The studies were conducted 
in 15 LMICs: 10 in Africa,37 40 41 43 47 51–53 59 60 8 in 
Asia,25 39 42 44 46 49 50 55 2 in the Middle East45 48 and 1 in 
South America38 (figure 4). In five studies, the country 
was not specified.22 54 56–58 The finding that the majority 
of studies took place in LMICs was not surprising as VA 
is predominantly used in countries where CRVS systems 
are incomplete or absent. Ten studies used a WHO VA 
tool,38 39 43 45–48 56 58 60 two an adapted version developed 
by INDEPTH,52 53 two used the PHMRC tool49 59 and one 
applied a study-specific tool (Vital Registration and VA 
tool).40 Eleven studies mentioned the use of a VA tool 
but gave no specifics on which.22 25 37 41 42 44 50 51 54 55 57 
For data collection with VA, five stated the use of elec-
tronic devices,40 49 52 56 60 two used paper-based ques-
tionnaires,42 50 while the remaining studies did not state 
how data were collected. Eight mentioned the addi-
tional use of questionnaires investigating social deter-
minants.37 40 43 44 47 48 53 59 Specifics of how governments 
Figure 3 Literature search and review process.
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were involved in the process varied considerably. In eight 
studies, government involvement was in more than one 
element of the process: five studies described involve-
ment in planning and research programme implemen-
tation,37–39 49 52 and in three studies, in implementation 
and scale up.45 48 59 In a further nine studies, govern-
ment involvement was described in a single element 
of the process: five in implementation,25 41 43 46 47 two 
in scale up,44 60 one in funding support,50 and one 
through a working relationship which was stated but not 
described,53 respectively (online supplementary table 1). 
Twelve studies were conducted within established routine 
health information systems,25 38 40 41 46 49–53 59 60 and eight 
introduced or established new methods of data collec-
tion on cause of death.37 39 42–45 47 48
Implementation features
VA was used to ascertain cause of death predomi-
nantly in studies where no other form of certifica-
tion was available22 54 58 60 or for deaths outside facili-
ties,25 40 45–49 investigating mainly maternal, child and 
neonatal deaths.37 41 43–45 47 48 53 59 Other studies used 
VA in demographic surveillance sites in conjunction 
with epidemiological and demographic research,50–53 
and for recording and investigating deaths in HDSS 
for the purposes of informing health policy and plan-
ning.38 40 42 46 50–52 55 60
Through methodological advances, and often 
with reference to the use of CCVA, VA was stated to 
have become a valued and feasible approach for use 
outside research settings, for wider application in 
health systems and policy as well as in national CRVS 
systems.22 25 38 40 42 46 48 49 54–56 58 60 This was supported by 
the study from Joshi et al,42 which investigated the cost of 
a VA-based mortality surveillance system in rural India. 
The study concluded that the approach was cost-effec-
tive (US$0.10 per capita per year), and that with data 
collection on electronic devices the cost could be further 
reduced.42 The authors demonstrated the use of VA in a 
mortality surveillance system as feasible, and as capable 
of providing valuable, timely evidence on cause of death 
for policymakers and health professionals.42
Other studies did not directly investigate costs but 
stated that cost savings could be achieved by conducting 
VA on a representative sample of all deaths or in a selec-
tion of registration administrative areas.22 As noted by 
Sankoh and Byass,56 the time and resource implications 
of establishing and maintaining CRVS systems inclusive 
of VA are inevitable, however the benefits that functional 
CRVS systems confer on people and societies are consid-
erable. These include enabling access to public goods, 
facilitating development across all sectors and delivering 
valuable information for health policy and planning.56 In 
this sense, the cost of not collecting vital information is 
acknowledged as far higher. Government funding and 
commitment, as well as support and governance through 
an independent body, were also recommended  to ensure 
longevity, continued evolution and provision of academic 
freedom to achieve this.43 44 50
Several studies described VA as an applicable tool that 
adds value across intersectoral domains and beyond 
public health.38 40–42 44 50 59 60 These included ministries 
of health, local governments, specialised agencies (eg, 
national and international organisations), national 
health insurance, local health authorities, health 
Figure 4 Countries in which verbal autopsy (VA) studies were conducted and reported in scientific literature 2010-2017.
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facilities, community workers as well as departments of 
justice and interior.22 43 54 Several authors recommended 
an interdisciplinary and intersectoral approach that 
combines empirical and analytical efforts with different 
organisations, stakeholders and the community to 
enable functional registration in poorly resourced 
health systems.22 37 44 47 53 59 In the paper by Bensaïd 
et al,59 an intersectoral collaboration is described to 
demonstrate the power of implementing surveillance 
and response interventions in settings with high levels 
of mortality. The collaborative effort was initiated by the 
government of Niger and implemented by the National 
Statistics Institute and a VASA working group including 
the MOH, the Niger country office of UNICEF and 
other partners in partnership with the John Hopkins 
School of Public Health, which provided technical assis-
tance on behalf of WHO/UNICEF and supported by 
CHERG.59
Furthermore, communities were described as a critical 
foundation on which to build CRVS systems and ensure 
sustainability.37 44 52 54 So-called hybrid approaches, using 
a combination of reporting through community-based 
systems, for example, health facilities, burial authori-
ties, key informants as well as official registration, were 
detailed.22 38 58 Several authors pointed out, however, 
that communities should not be ‘used’ as passive data 
collectors but instead adopt roles as active partners in the 
surveillance and response processes.37 44 48 54 Authors also 
noted that this approach has the potential to generate 
self-sustaining sources of information on mortality, 
improve trust in health systems, and counteract the 
potential for 'community fatigue' from repeated data 
collection cycles.37 52
In this sense, active community involvement can 
enhance understandings of, and ultimately transform 
social exclusion from, access to health systems by shifting 
control over the production, use and exchange of knowl-
edge on health towards those most directly affected.54 
One example of such an approach was a pilot study by 
Bayley et al,37 which investigated a community-linked 
maternal death review (CLMDR) to measure and prevent 
maternal mortality.37 The study demonstrated that 
CLMDR improved identification and review of deaths, 
providing opportunities for education and stimulating 
action in facilities. Due to the success of this approach in 
a sample site in Malawi, the MOH initiated a nationwide 
roll-out of the programme.37
Studies employing VA to examine facility-based deaths 
were also identified. VA was described to become partic-
ularly important where postmortem pathological exam-
inations are not available, not mandatory, unreliable, 
or death certificates are issued for non-specific causes, 
which are of little value for public health decision 
making.22 38 55 58 De Savigny et al22 and Bayley et al37 note 
the importance of investigations of this nature when 
recording maternal deaths that were not attended by 
trained providers.
VA in health systems and policy
Of the papers reviewed, 18 explicitly acknowledged a 
close intersection between the use of VA methods, and 
the functions of the health system to improve popula-
tion health. This was achieved via: (1) active engagement 
of the government in the process,39 43 46 47 49 55 59 60 for 
example, high-level engagement of the Niger govern-
ment and stakeholders for dissemination of VASA study 
results to support policy development,59 (2) demands 
from, or working relationship with, governments/health 
authorities,38 45 48 50 52 53 for example, the request from the 
Ministry of Public Health in Afghanistan to expand an 
intervention programme to reduce maternal deaths,45 and 
(3) purposeful dissemination of information to govern-
mental, national and international agencies,37 40 41 51 58 for 
example, VA within the Millennium Global Village-Net-
work provided feedback to local providers.40
In combination with questionnaires about social deter-
minants, including as part of SA processes, VA was also 
used to identify social factors contributing to deaths and 
to determine gaps in health systems.44 52–54 SA has been 
reported as effective in supporting a more comprehen-
sive analysis of the extent to which interventions achieve 
intended effects or help to explain why actions to improve 
people’s health are not taken by community members or 
health authorities.44 47 53
The studies demonstrated that when other routinely 
collected data, for example, surveys on demographic 
characteristics, are supplemented with VA data on a 
regular basis, they can provide information that can 
help to enhance health planning, inform policies and 
contribute to health system strengthening. However, to 
do so, data need to be shared and interpreted at all levels, 
from communities to systems.38 40–42 44 46 47 52 54 59 60
strengths and limitations of VA for health systems and policy
According to the WHO, the gold standard for cause of 
death reporting is certification by a medical practitioner 
trained using the ICD system.61 However, in LMICs there 
is often insufficient supply of appropriate medical equip-
ment, trained forensic experts and pathologists. Cultural 
norms and traditions can also interfere with timing 
and performance of autopsies.38 46 As de Savigny et al22 
state, the absence of locally relevant gold standard data 
presents challenges in conducting locally applicable 
validation studies to determine the external validity of 
VA results. As stated above, VA has become increasingly 
standardised in recent years and more frequently applied 
globally, allowing for comparison with other standardised 
methods, for example, hospital records.56 58 The litera-
ture also acknowledged, however, the value of adapta-
tions to context, and that standardisation may inadvert-
ently compromise accuracy, completeness and validity, 
limiting relevance to local policy and planning.22 49 54 58
Use of mobile devices and electronic databases, 
‘mHealth’, was a relatively new development affecting how 
VA is used. Electronic platforms were frequently described 
as able to enhance data sharing and link data of a range 
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of types and sources: demographic, epidemiological, 
mortality, morbidity, clinical, laboratory, household, 
environmental, health system for a more holistic view.57 
National electronic records systems, ‘SmartCare’ in 
Zambia,62 for example, have been reported to create new 
opportunities to enhance the timeliness of data collec-
tion and analysis, among others with VASA, enabling 
real-time data capture.22 40 47 52 53 60 These advances were 
reported to assist in the detection of rapid changes in 
health systems and disease burdens, as well as track key 
indicators related to local, regional and global goals and 
associated targets,48 59 aiding in efficient decision making 
and delivery of care.25 40
Encouraging the use of VA in countries lacking 
adequate or representative data via the expansion of 
HDSS, and with VA complementing hospital data were 
also seen as promising approaches.22 38 41 De Savigny et al22 
recommend that data gathered with VA in the commu-
nity should be analysed with physician-certified hospital 
deaths. To realise potential, it was further recognised that 
expansion of infrastructure and collaboration between 
research and service organisation and delivery are neces-
sary.54 In South Africa, for example, the Department of 
Science and Technology has recently launched an initia-
tive to consolidate three existing HDSS sites and expand 
the platform with three further urban and rural nodes, to 
cover over 1% of the national population.63
dIsCussIon And ConClusIon
This review sought to examine how VA is used in a manner 
consistent with the emerging health policy and system 
research paradigm.33 The review fills an important gap in 
the literature on how VA is (and can be) used to support 
the routine operation of health systems, not just in terms 
of surveillance but in policy and programme devel-
opment. Further, it explores its use in an ‘embedded’ 
manner in health policy and systems research, working 
with planners and implementers.
A number of limitations of this review need to be 
acknowledged. Findings may have been influenced by 
publication and reporting bias. The search may have 
missed studies in which VA was used in health policy and 
systems due to the lack of uniform reporting or indexing 
methods. Many key studies are also reported in the grey 
literature, with uneven quality and variable availability. 
On this basis, grey literature was included to increase the 
breadth, relevance and utility of the review.
The studies identified were conducted in 15 LMICs 
in Africa, Asia and South America using mostly stan-
dardised VA tools to investigate generally maternal and 
child mortality. Of the studies selected, eight used VA 
‘embedded’ in projects investigating the effectiveness of 
single or multiple interventions implemented in the study 
area. Four used VA in established HDSS sites to ascertain 
cause of death in the population, while the remaining 
studies looked at the feasibility of VA in national health 
and vital registration systems.
The studies either disseminated data to health author-
ities and government representatives or stated the 
direct involvement of a government representative in 
the process (ie, in planning, implementation and/or 
scale-up). A notable shift in the time period covered by 
this review was the application and use of VA beyond 
research settings. The method has been developed to 
enhance appropriateness and feasibility of implementa-
tion in vital registration where information gathered is 
actively and routinely used by health authorities. The 
review revealed a continued transition of the VA method 
beyond research environments into health policy and 
planning, contributing to achievements in, and demon-
strating of progress towards UHC and other targets. With 
methodological advancements and technical develop-
ments, it is regarded as a valuable and feasible approach 
to supplement and strengthen national sample and 
CRVS systems in LMICs.22 38 49 58 The increasing use of 
electronic means to collect, compute and share real-time 
data, for example, using tablets, CCVA, e-health and 
mHealth  recording systems, is also contributing to devel-
opment and use on a wider scale and routine basis.22 49 62 64
An intersectoral focus and the involvement of commu-
nities were reported as further key developments to the 
method, which were seen to facilitate sustainability. Here 
an important tension was identified whereby despite 
efforts to standardise and generate comparable data 
across settings, it was noted that VA is not a one-size-
fits-all approach,20 and adaptations to local conditions 
were described as critical for maintaining relevance 
to national and local health contexts.10 13 Standardised 
and validated VA were also described as important 
for evidence-based resource allocation when used by 
regional, national, cross-national and international 
actors.65 Moreover, when VA is used in conjunction with 
other data collection methods, for example, SA on demo-
graphic and health system characteristics, a more holistic 
view of health systems performance was achieved.
Improving CRVS systems in LMICs was described to 
involve national policymakers and governments, and to 
require commitments from the global health commu-
nity to help fund and build these systems. This was seen 
to require an interdisciplinary and intersectoral effort 
involving a variety of organisations and stakeholders such 
as MOHs, ministries of local government, national and 
international agencies, as well as health facilities and 
researchers. There was also evidence of merit in the 
involvement of communities and families living in regis-
tration sites.37 44 52 54 Several partnerships models were 
seen to help extend CRVS systems in settings lacking 
resources and capacity, fostering improved health systems 
performance and, ultimately, reductions in avoidable 
mortality.22 38 58
There is a growing demand for evidence-based and 
data-driven interventions in LMICs. With new technolo-
gies facilitating data collection and analysis,  and in combi-
nation with supplementary data collection methods, VA 
is used in a versatile manner beyond research settings 
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to inform policy, programming and planning. Where 
governments are involved in the planning, implementa-
tion and/or scale-up of VA activities, information tended 
to be used more directly in planning and policy processes. 
Increasing coverage and use of VA on a routine and 
continuous basis may offer information gains on many 
fronts: to inform local health institutions and policy 
development, and in planning and research at national 
and global levels. Data that are developed collaboratively 
and communicated effectively, recognising strengths and 
limitations, were further promising developments. The 
literature  reviewed suggests that VA has potential to help 
close the gaps in the availability and use of intelligence, 
and guide policy implementation, evaluation and invest-
ment in health systems.
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